Grant of share options
Nykode Therapeutics ASA (NYKD) · publisert 2023-07-07 15:01 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Michael Engsig | – | other | 423 878 | 0 NOK | 2023-07-07 | NO0010714785 | Outside of trading venue | rules · til gjennomgang |
| Harald Gurvin | – | other | 167 876 | 0 NOK | 2023-07-07 | NO0010714785 | Outside of trading venue | rules · til gjennomgang |
| Agnete B. Fredriksen | – | other | 154 446 | 0 NOK | 2023-07-07 | NO0010714785 | Outside of trading venue | rules · til gjennomgang |
| Mikkel W. Pedersen | – | other | 156 108 | 0 NOK | 2023-07-07 | NO0010714785 | Outside of trading venue | rules · til gjennomgang |
| Klaus Edvardsen | – | other | 193 322 | 0 NOK | 2023-07-07 | NO0010714785 | Outside of trading venue | rules · til gjennomgang |
Vedlegg
- Attachment 230707.pdf (tekst hentet ut)
Meldingstekst
Oslo, Norway, July 7, 2023 - A total of 2,510,889 share options have been granted to employees of Nykode Therapeutics ASA under the company’s share option scheme, of which 1,095,630 share options have been granted to primary insiders. The share options will have a strike price of NOK 28.47 per share, have a five-year term and will vest equally over a four-year vesting period.
Please see further details in attached document.